Cargando…
Modification of phosphoinositides by the Shigella effector IpgD during host cell infection
Shigella, the causative agent of bacillary dysentery, subvert cytoskeletal and trafficking processes to invade and replicate in epithelial cells using an arsenal of bacterial effectors translocated through a type III secretion system. Here, we review the various roles of the type III effector IpgD,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647168/ https://www.ncbi.nlm.nih.gov/pubmed/36389142 http://dx.doi.org/10.3389/fcimb.2022.1012533 |
_version_ | 1784827327436292096 |
---|---|
author | Tran Van Nhieu, Guy Latour-Lambert, Patricia Enninga, Jost |
author_facet | Tran Van Nhieu, Guy Latour-Lambert, Patricia Enninga, Jost |
author_sort | Tran Van Nhieu, Guy |
collection | PubMed |
description | Shigella, the causative agent of bacillary dysentery, subvert cytoskeletal and trafficking processes to invade and replicate in epithelial cells using an arsenal of bacterial effectors translocated through a type III secretion system. Here, we review the various roles of the type III effector IpgD, initially characterized as phosphatidylinositol 4,5 bisphosphate (PI4,5P(2)) 4-phosphatase. By decreasing PI4,5P(2) levels, IpgD triggers the disassembly of cortical actin filaments required for bacterial invasion and cell migration. PI5P produced by IpgD further stimulates signaling pathways regulating cell survival, macropinosome formation, endosomal trafficking and dampening of immune responses. Recently, IpgD was also found to exhibit phosphotransferase activity leading to PI3,4P(2) synthesis adding a new flavor to this multipotent bacterial enzyme. The substrate of IpgD, PI4,5P(2) is also the main substrate hydrolyzed by endogenous phospholipases C to produce inositoltriphosphate (InsP(3)), a major Ca(2+) second messenger. Hence, beyond the repertoire of effects associated with the direct diversion of phoshoinositides, IpgD indirectly down-regulates InsP(3)-mediated Ca(2+) release by limiting InsP(3) production. Furthermore, IpgD controls the intracellular lifestyle of Shigella promoting Rab8/11 -dependent recruitment of the exocyst at macropinosomes to remove damaged vacuolar membrane remnants and promote bacterial cytosolic escape. IpgD thus emerges as a key bacterial effector for the remodeling of host cell membranes. |
format | Online Article Text |
id | pubmed-9647168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96471682022-11-15 Modification of phosphoinositides by the Shigella effector IpgD during host cell infection Tran Van Nhieu, Guy Latour-Lambert, Patricia Enninga, Jost Front Cell Infect Microbiol Cellular and Infection Microbiology Shigella, the causative agent of bacillary dysentery, subvert cytoskeletal and trafficking processes to invade and replicate in epithelial cells using an arsenal of bacterial effectors translocated through a type III secretion system. Here, we review the various roles of the type III effector IpgD, initially characterized as phosphatidylinositol 4,5 bisphosphate (PI4,5P(2)) 4-phosphatase. By decreasing PI4,5P(2) levels, IpgD triggers the disassembly of cortical actin filaments required for bacterial invasion and cell migration. PI5P produced by IpgD further stimulates signaling pathways regulating cell survival, macropinosome formation, endosomal trafficking and dampening of immune responses. Recently, IpgD was also found to exhibit phosphotransferase activity leading to PI3,4P(2) synthesis adding a new flavor to this multipotent bacterial enzyme. The substrate of IpgD, PI4,5P(2) is also the main substrate hydrolyzed by endogenous phospholipases C to produce inositoltriphosphate (InsP(3)), a major Ca(2+) second messenger. Hence, beyond the repertoire of effects associated with the direct diversion of phoshoinositides, IpgD indirectly down-regulates InsP(3)-mediated Ca(2+) release by limiting InsP(3) production. Furthermore, IpgD controls the intracellular lifestyle of Shigella promoting Rab8/11 -dependent recruitment of the exocyst at macropinosomes to remove damaged vacuolar membrane remnants and promote bacterial cytosolic escape. IpgD thus emerges as a key bacterial effector for the remodeling of host cell membranes. Frontiers Media S.A. 2022-10-27 /pmc/articles/PMC9647168/ /pubmed/36389142 http://dx.doi.org/10.3389/fcimb.2022.1012533 Text en Copyright © 2022 Tran Van Nhieu, Latour-Lambert and Enninga https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Tran Van Nhieu, Guy Latour-Lambert, Patricia Enninga, Jost Modification of phosphoinositides by the Shigella effector IpgD during host cell infection |
title | Modification of phosphoinositides by the Shigella effector IpgD during host cell infection |
title_full | Modification of phosphoinositides by the Shigella effector IpgD during host cell infection |
title_fullStr | Modification of phosphoinositides by the Shigella effector IpgD during host cell infection |
title_full_unstemmed | Modification of phosphoinositides by the Shigella effector IpgD during host cell infection |
title_short | Modification of phosphoinositides by the Shigella effector IpgD during host cell infection |
title_sort | modification of phosphoinositides by the shigella effector ipgd during host cell infection |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647168/ https://www.ncbi.nlm.nih.gov/pubmed/36389142 http://dx.doi.org/10.3389/fcimb.2022.1012533 |
work_keys_str_mv | AT tranvannhieuguy modificationofphosphoinositidesbytheshigellaeffectoripgdduringhostcellinfection AT latourlambertpatricia modificationofphosphoinositidesbytheshigellaeffectoripgdduringhostcellinfection AT enningajost modificationofphosphoinositidesbytheshigellaeffectoripgdduringhostcellinfection |